Eden Research (LON:EDEN) Stock Price Down 3.3% – Here’s What Happened

Posted by Floyd Graber on Feb 23rd, 2025

Eden Research plc (LON:EDEN – Get Free Report) shares traded down 3.3% during trading on Saturday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The firm has a 50 day simple moving average of GBX 3.87 and a 200 day simple moving average of GBX 3.95. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The firm has a market capitalization of £18.56 million, a PE ratio of -12.19 and a beta of 0.92.

Insider Buying and Selling at Eden Research

In other news, insider Lykele van der Broek purchased 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey purchased 540,540 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was purchased at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.